Targeted Therapy

253 molecules in this therapeutic area. Open any product for its details, or send an inquiry directly.

Connect With Us

Targeted Therapy (32)

Quick filters: Solid Tumour Hematologic Both Name A-Z Name Z-A

Therapeutic Areas

Sort by

Clear all filters

Molecule	Drug Class / Mechanism	Oncology Type
Alpelisib	PI3K Inhibitor	Both (Solid & Hematologic)
Molecule Alpelisib Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism PI3K Inhibitor
APG-115 (Alrizomadlin)	MDM2 Inhibitor	Both (Solid & Hematologic)
Molecule APG-115 (Alrizomadlin) Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism MDM2 Inhibitor
Brigimadlin	MDM2 Inhibitor	Both (Solid & Hematologic)
Molecule Brigimadlin Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism MDM2 Inhibitor
Buparlisib	PI3K Inhibitor	Both (Solid & Hematologic)
Molecule Buparlisib Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism PI3K Inhibitor
Copanlisib	PI3K Inhibitor	Both (Solid & Hematologic)
Molecule Copanlisib Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism PI3K Inhibitor
Duvelisib	PI3K Inhibitor	Both (Solid & Hematologic)
Molecule Duvelisib Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism PI3K Inhibitor
Everolimus	mTOR Inhibitor	Both (Solid & Hematologic)
Molecule Everolimus Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism mTOR Inhibitor
Gedatolisib	PI3K Inhibitor	Both (Solid & Hematologic)
Molecule Gedatolisib Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism PI3K Inhibitor
Glasdegib	Hedgehog Pathway Inhibitor	Solid Tumour / Hematologic (AML)
Molecule Glasdegib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour / Hematologic (AML) Drug Class / Mechanism Hedgehog Pathway Inhibitor
Idasanutlin	MDM2 Inhibitor	Both (Solid & Hematologic)
Molecule Idasanutlin Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism MDM2 Inhibitor
Idelalisib	PI3K Inhibitor	Both (Solid & Hematologic)
Molecule Idelalisib Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism PI3K Inhibitor
Inavolisib	PI3K Inhibitor	Both (Solid & Hematologic)
Molecule Inavolisib Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism PI3K Inhibitor

Alpelisib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism PI3K Inhibitor
APG-115 (Alrizomadlin) Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism MDM2 Inhibitor
Brigimadlin Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism MDM2 Inhibitor
Buparlisib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism PI3K Inhibitor
Copanlisib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism PI3K Inhibitor
Duvelisib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism PI3K Inhibitor
Everolimus Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism mTOR Inhibitor
Gedatolisib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism PI3K Inhibitor
Glasdegib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour / Hematologic (AML) Drug Class / Mechanism Hedgehog Pathway Inhibitor
Idasanutlin Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism MDM2 Inhibitor
Idelalisib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism PI3K Inhibitor
Inavolisib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism PI3K Inhibitor

‹ 1 2 3 ›

Product Range

Company

Global Network

Targeted Therapy

Targeted Therapy (32)

Alpelisib

APG-115 (Alrizomadlin)

Brigimadlin

Buparlisib

Copanlisib

Duvelisib

Everolimus

Gedatolisib

Glasdegib

Idasanutlin

Idelalisib

Inavolisib

Alpelisib

APG-115 (Alrizomadlin)

Brigimadlin

Buparlisib

Copanlisib

Duvelisib

Everolimus

Gedatolisib

Glasdegib

Idasanutlin

Idelalisib

Inavolisib